Nuvalent, Inc. (NUVL)
NASDAQ·Healthcare·Biotechnology
$123.36
-0.02%
Mkt Cap $9.07B
Analyst Ratings
Buy
5
Hold
10
Sell
0
Price Target (20 analysts)
$137.44
Range $120.00 – $155.00
Implied Upside
+11.4%
Consensus $137.44 vs current $123.36
NASDAQ·Healthcare·Biotechnology
$123.36
-0.02%
Mkt Cap $9.07B
Buy
5
Hold
10
Sell
0
Price Target (20 analysts)
$137.44
Range $120.00 – $155.00
+11.4%
Consensus $137.44 vs current $123.36